Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Zenz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Arthritis Research & Therapy|September 28, 2024
Patients' recollection about the onset of Sjögren's disease - a mixed methods study on the patients' perspectiveAngelika Lackner, Barbara Dreo, Josef Hermann, et al.
Frontiers in Medicine|May 3, 2021
Go Ask Your Patients! PSS-QoL Reported Perception of Dryness Correlates With Lacrimal and Salivary Flow in Primary Sjögren's SyndromeAngelika Lackner, Philipp Bosch, Sabine Zenz, et al.
International Journal of Clinical Practice|February 4, 2021
Effect of short-interval rituximab and high-dose corticosteroids on kidney function in systemic sclerosis: Long-term experience of a single centreBalazs Odler, Carina Hebesberger, Lukas Hoeflechner, et al.
Therapeutic Advances in Musculoskeletal Disease|May 31, 2022
Sjögren syndrome: looking forward to the futureSara Zandonella Callegher, Ivan Giovannini, Sabine Zenz, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 2022
Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide-Positive Type 1 Diabetes During HypoglycemiaSabine Zenz, Werner Regittnig, Beate Boulgaropoulos, et al.
Diabetes, Obesity & Metabolism|February 17, 2017
Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetesFelix Aberer, Martin Hajnsek, Markus Rumpler, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2018
Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DMSabine Zenz, Julia K Mader, Werner Regittnig, et al.
Journal of Personalized Medicine|July 2, 2021
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic SclerosisPaul Gressenberger, Philipp Jud, Gabor Kovacs, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Arthritis Research & Therapy|September 28, 2024
Patients' recollection about the onset of Sjögren's disease - a mixed methods study on the patients' perspectiveAngelika Lackner, Barbara Dreo, Josef Hermann, et al.
Frontiers in Medicine|May 3, 2021
Go Ask Your Patients! PSS-QoL Reported Perception of Dryness Correlates With Lacrimal and Salivary Flow in Primary Sjögren's SyndromeAngelika Lackner, Philipp Bosch, Sabine Zenz, et al.
International Journal of Clinical Practice|February 4, 2021
Effect of short-interval rituximab and high-dose corticosteroids on kidney function in systemic sclerosis: Long-term experience of a single centreBalazs Odler, Carina Hebesberger, Lukas Hoeflechner, et al.
Therapeutic Advances in Musculoskeletal Disease|May 31, 2022
Sjögren syndrome: looking forward to the futureSara Zandonella Callegher, Ivan Giovannini, Sabine Zenz, et al.
The Journal of Clinical Endocrinology and Metabolism|July 14, 2022
Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide-Positive Type 1 Diabetes During HypoglycemiaSabine Zenz, Werner Regittnig, Beate Boulgaropoulos, et al.
Diabetes, Obesity & Metabolism|February 17, 2017
Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetesFelix Aberer, Martin Hajnsek, Markus Rumpler, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2018
Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DMSabine Zenz, Julia K Mader, Werner Regittnig, et al.
Journal of Personalized Medicine|July 2, 2021
Rituximab as a Treatment Option after Autologous Hematopoietic Stem Cell Transplantation in a Patient with Systemic SclerosisPaul Gressenberger, Philipp Jud, Gabor Kovacs, et al.
Pageof 1